Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.690
+0.010 (0.21%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Lifecore Biomedical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Lifecore Biomedical stock has a consensus rating of "Buy" and an average price target of $6.83. The average 1-year stock price forecast is 45.63% higher than the current stock price, while the lowest is $5.00 (+6.61%) and the highest is $9.00 (+91.90%).
Price Target: $6.83 (+45.63%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jun 16, 2026.
Analyst Ratings
The average analyst rating for Lifecore Biomedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 6, 2026 |
| Barrington | Barrington | Buy Maintains $6 → $6.5 | Buy | Maintains | $6 → $6.5 | +38.59% | Jun 16, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 6, 2026 |
| Stephens | Stephens | Hold Reiterates $8.5 → $5 | Hold | Reiterates | $8.5 → $5 | +6.61% | Mar 17, 2026 |
Financial Forecast
Revenue This Year
122.17M
from 128.87M
Decreased by -5.63%
Revenue Next Year
130.23M
from 122.17M
Increased by 6.60%
EPS This Year
-0.81
from -0.43
EPS Next Year
-0.81
from -0.81
EPS and Forward PE are based on non-GAAP adjusted numbers.